PAX5 alterations in an infant case of KMT2A-rearranged leukemia with lineage switch

被引:3
|
作者
Nakajima, Koji [1 ]
Kubota, Hirohito [1 ]
Kato, Itaru [1 ]
Isobe, Kiyotaka [1 ]
Ueno, Hiroo [1 ]
Kozuki, Kagehiro [1 ]
Tanaka, Kuniaki [1 ]
Kawabata, Naoko [1 ]
Mikami, Takashi [1 ]
Tamefusa, Kosuke [2 ]
Nishiuchi, Ritsuo [2 ]
Saida, Satoshi [1 ]
Umeda, Katsutsugu [1 ]
Hiramatsu, Hidefumi [1 ]
Adachi, Souichi [3 ]
Takita, Junko [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan
[2] Kochi Hlth Sci Ctr, Dept Pediat, Kochi, Japan
[3] Kyoto Univ, Grad Sch Med, Dept Human Hlth Sci, Kyoto, Japan
关键词
infant leukemia; KMT2A rearrangement; lineage switch; PAX5; whole exome sequencing; CELL;
D O I
10.1111/cas.15380
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lineage switch is a rare event at leukemic relapse. While mostly known to occur in KMT2A-rearranged infant leukemia, the underlying mechanism is yet to be depicted. This case report describes a female infant who achieved remission of KMT2A-MLLT3-rearranged acute monocytic leukemia, but 6 months thereafter, relapsed as KMT2A-MLLT3-rearranged acute lymphocytic leukemia. Whole exome sequencing of the bone marrow obtained pre-post lineage switch revealed two somatic mutations of PAX5 in the relapse sample. These two PAX5 alterations were suggested to be loss of function, thus to have played the driver role in the lineage switch from acute monocytic leukemia to acute lymphocytic leukemia.
引用
收藏
页码:2472 / 2476
页数:5
相关论文
共 50 条
  • [31] PAX5 alterations in B-cell acute lymphoblastic leukemia
    Jia, Zhilian
    Gu, Zhaohui
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [32] COMBINATORIAL IMMUNOTHERAPEUTIC AND TARGETED KINASE INHIBITION APPROACH IN KMT2A-REARRANGED ACUTE LYMPHOBLASTIC LEUKEMIA
    Niswander, Lisa
    Mcclellan, Samantha
    Shraim, Rawan
    Falkenstein, Catherine
    Yarnell, Michael
    Meadows, Christina
    Fry, Terry
    Tasian, Sarah
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S117 - S117
  • [33] Interrogating bromodomain inhibitor resistance in KMT2A-rearranged leukemia through combinatorial CRISPR screens
    Wright, Shaela
    Hu, Jianzhong
    Wang, Hong
    Hyle, Judith
    Du, Guoqing
    Zhang, Yang
    Konopleva, Marina Y.
    Kornblau, Steven M.
    Djekidel, Mohamed Nadhir
    Rosikiewicz, Wojciech
    Xu, Beisi
    Lu, Rui
    Yang, Jun J.
    Li, Chunliang
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (16)
  • [34] Brachial plexus chloroma as a presenting feature of relapse in a child with KMT2A-rearranged acute lymphoblastic leukemia, a case report
    Pruitt, Jamie
    Flagg, Aron
    Hanna, Rabi
    Rotz, Seth J.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2021, 38 (02) : 179 - 183
  • [35] Fusion and flow: refining risk prediction in KMT2A-rearranged pediatric acute myeloid leukemia
    Conneely, Shannon E.
    Rau, Rachel E.
    TRANSLATIONAL PEDIATRICS, 2023, 12 (12) : 2099 - 2102
  • [36] Novel Compounds Synergize With Venetoclax to Target KMT2A-Rearranged Pediatric Acute Myeloid Leukemia
    Tregnago, Claudia
    Benetton, Maddalena
    Da Ros, Ambra
    Borella, Giulia
    Longo, Giorgia
    Polato, Katia
    Francescato, Samuela
    Biffi, Alessandra
    Pigazzi, Martina
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [37] Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia
    Burmeister, Thomas
    Stroeh, Aeint-Steffen
    Kehden, Britta
    Trautmann, Heiko
    Meyer, Claus
    Marschalek, Rolf
    Larghero, Patrizia
    Schwartz, Stefan
    Steffen, Bjoern
    Spriewald, Bernd
    Heinicke, Thomas
    Jaekel, Nadja
    Westermann, Joerg
    Nachtkamp, Kathrin
    Viardot, Andreas
    Topp, Max S.
    Neumann, Martin
    Baldus, Claudia D.
    Goekbuget, Nicola
    Brueggemann, Monika
    LEUKEMIA, 2024, 38 (07) : 1600 - 1603
  • [38] LINEAGE SWITCH IN KMT2A REARRANGED LEUKEMIA DURING BLINATUMOMAB THERAPY ACCOMPANIED BY IMMUNOLOGICAL CHANGE ANALOGOUS TO MDSC
    Mikami, Takashi
    Kato, Itaru
    Wing, James
    Tasaka, Keiji
    Kamitori, Tatsuya
    Kubota, Hirohito
    Hiramatsu, Hidefumi
    Ogawa, Seishi
    Sakaguchi, Shimon
    Takita, Junko
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [39] A Pediatric Case of KMT2A-Rearranged Diffuse Large B-cell Lymphoma
    Kato, Shota
    Kubota, Yasuo
    Takasugi, Nao
    Hidaka, Moe
    Sekiguchi, Masahiro
    Watanabe, Kentaro
    Takita, Junko
    Hiwatari, Mitsuteru
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [40] Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemia
    Vetro, Calogero
    Haferlach, Torsten
    Meggendorfer, Manja
    Stengel, Anna
    Jeromin, Sabine
    Kern, Wolfgang
    Haferlach, Claudia
    CANCER GENETICS, 2020, 240 : 15 - 22